Molecular characterization of human T-cell leukemia virus type 1 gp46 glycoprotein from healthy carriers and tropical spastic paraparesis/HTLV-associated myelopathy infected individuals by Aline CA Mota-Miranda et al.
POSTER PRESENTATION Open Access
Molecular characterization of human T-cell
leukemia virus type 1 gp46 glycoprotein from
healthy carriers and tropical spastic paraparesis/
HTLV-associated myelopathy infected individuals
Aline CA Mota-Miranda1,2,3, Fernanda K Barreto1, Maria FC Amarante4, Everton Baptista1,
Joana P Monteiro-Cunha1,2,3, Lourdes Farre-Valve1, Bernardo Galvao-Castro1,2, Luiz CJ Alcantara1*
From 16th International Conference on Human Retroviruses: HTLV and Related Viruses
Montreal, Canada. 26-30 June 2013
The present study attempts to assess the molecular diver-
sity of gp46 glycoprotein in HAM/TSP patients and
Health Carrier (HC) individuals. The median HTLV-1
proviral load of HC (n=5) and HAM/TSP (n=5) patients
was similar (average 316,227 copies/106 PBMCs). The
gp46 molecular characterization of 146 clones (70 HC and
76 HAM/TSP) revealed an overall diversity, within HC
and HAM/TSP clones, of 0.4% and 0.6%, respectively. A
single amino acid (aa) substitution (S35L) was exclusive
for the HC group, and three gp46 substitutions (F14S,
N42H, G72S) were exclusive for the HAM/TSP group.
The remaining frequent mutation (V247I) was present in
both groups (p = 0.0014). The in silico protein analysis
revealed that the mutated alleles F14S and N42H repre-
sent more hydrophilic and flexible protein domains that
are likely to be less antigenic. The Receptor Binding
Domain is quite variable in the HAM/TSP group. Two
other domains (aa 53-75 and 175-209) that contain multi-
ple linear T-cell epitopes showed genetic diversity in both
HAM/TSP and HC groups. Further analysis revealed
27 and 13 T-cell epitopes for class I HLA alleles and class
II HLA alleles, when analyzing the entire gp46. We still
cannot associate any of the gp46 found mutations with the
clinical profile.
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